SALIX PHARMACEUTICALS LTD Business Combination, Consideration Transferred
SALIX PHARMACEUTICALS LTD reported Business Combination, Consideration Transferred of $2.67 billion for the 0-month period ending 2014-01-02, per its 10-Q/A filed 2015-03-02.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2015-03-02
- 2014-01-02: Business Combination, Consideration Transferred 0 month $2.67B; Business Combination, Consideration Transferred $2.67B.
| Period end | Business Combination, Consideration Transferred 0 month | Business Combination, Consideration Transferred |
|---|---|---|
| 2014-01-02 | $2.67B 10-Q/A · filed 2015-03-02 | $2.67B 10-Q/A · filed 2015-03-02 |